Background Melanomas arising from eyelid skin are exceptionally rare, accounting for <1% of eyelid malignancies and all cutaneous melanomas. The aim of this study was to
Introduction
Eyelid tumors are the most common neoplasms encountered in ophthalmology practice and represent between 5 and 10% of all skin cancers. [1] [2] [3] [4] [5] [6] [7] The most frequent types encountered, listed in order of decreasing frequency, are basal cell carcinoma, squamous cell carcinoma, sebaceous cell carcinoma, Merkel cell carcinoma, and cutaneous melanoma. 1 However, melanoma arising from eyelid skin is exceptionally rare, accounting for <1% of eyelid malignancies and nearly 1% of all cutaneous melanomas. 2 The age-adjusted incidence rate for melanoma of the eyelid was 0.08 cases per 100,000 populations per year in the USA. 2 Due to the rarity of the disease, only a limited number of studies, including case report 8 and small case series, [9] [10] [11] [12] [13] have investigated the clinicopathological features of eyelid melanoma patients. Since primary eyelid melanoma has not been studied specifically in Turkish population before, we aimed to identify the clinicopathological characteristics and the outcome of palpebral melanoma in Turkish adult patients from a single tertiary referral institution. 
Materials and Methods

Results
A total of 17 eyelid-localized melanoma patients were included in the study. The median age of patients was 59 years (ranging from 23 to 71 years), and females were predominant in number (n = 11, 65%) ( Table 1 ). The numbers of lesions on the right and left side were identical (n = 8, on each side). The most common localization of the lesions was the lower eyelid (n = 8); only three patients had lesions on their upper eyelids. The remaining six patients had predominantly canthal involvement associated with lid extensions that affected inner and outer sites equally. Nodular, lentigo maligna, and the superficial spreading melanomas were the most commonly encountered histopathological subtypes, found in 4, 3, and 3 patients, respectively, and three patients had in situ melanomas. Tumor depth, invasion level, and mitotic rates were well-balanced among the patients ( Table 1 ).
The majority of the lesions were ulcerated, and the regression was absent in tumors. Tumor-infiltrating lymphocytes were predominant in the patients; however, a few lesions had lymphovascular invasion, and no lesions had neurotropism. The regional lymph node involvement and the distant organ metastasis existed in two and one patients, respectively.
Only four patients (24%) developed disease relapse, all of which were locoregional recurrences that involved lymph nodes (n = 1), and one patient developed in-transit metastasis ( Table 1) . The median RFS time and 5-year RFS rate were 26.3 months (ranging from 6.7 to 85.8 months) and 60.4%, respectively (Fig. 1 ). The patients with nodular histopathology (P = 0.02) and lymphovascular invasion (P = 0.05) had worse RFS compared with other patient and disease characteristics ( Table 2) .
Only two patients (12%) died at the time of the analysis (Table 1 ). The median OS time was 32.1 months (ranging from 12.1 to 106.2 months), and 5-year OS rate was 84% (Fig. 2) . Advanced age (older than 60 years of age) (P = 0.05), melanomas originated on canthus compared to eyelid (P = 0.03), and presence of recurrence (P = 0.04) have been found as poor prognostic indicators for OS (Table 2) .
Discussion
In this trial, we analyzed the data of 17 palpebral melanoma patients from a single tertiary center to define the histopathological and clinical characteristics of the disease along with recurrence and survival rates of the patients. We found that eyelid melanomas affected predominantly females and older patients and more frequently afflicted lower eyelids. Furthermore, these melanoma lesions were equally distributed tumors as per histopathology, Breslow thickness, Clark invasion, and mitotic rate. They lacked regression and neurotropism; however, they were mostly ulcerated and associated with excessive tumor-infiltrating lymphocytes. We also concluded that eyelid melanoma lesions coexisted with low rates of lymhovascular invasion. At admission, only two patients had lymph node involvementboth were N1, and there was only one case with distant metastasis -lung and liver. During the follow-up of these early stage patients, four patients developed locoregional relapses, and no distant metastasis occurred. Nodular histopathology and lymphovascular invasion were found mere poor prognostic indicators for RFS. Furthermore, only two patients died, and advanced age, lesions that arose on canthus, and presence of relapse have been found in association with poor prognosis for OS. As a result, we conclude that the palpebral melanoma has a more favorable prognosis and outcome than the cutaneous melanoma.
In general, our findings concur with a small number of studies that consist of only case reports 8 and small case series. 9-13 Kostopoulos et al. retrospectively analyzed 23 Greek patients with eyelid melanomas, and they found a strong female predominance (69.5%) among this group. 9 Median age was 68.5 years, and most of the tumors were located on the right inferior eyelids (71.4%). Lentigo maligna melanoma had the higher incidence Tas and Erturk Eyelid skin melanoma Reportmelanomas were investigated in terms of clinical and histopathological features. 11 While there was no gender predilection, the lower eyelid was found more frequently involved than the upper eyelid or canthi. Majority of the tumors had invasive nature (74%), and others were in situ (26%). Lentigo maligna melanoma was the most common histopathological type (61%) and followed by superficial spreading (22%) and nodular melanoma (17%). Three of 14 patients who had initial narrow excisions developed local relapses (21.4%), and only one case had distant metastasis and deceased. The authors suggested that eyelid skin melanomas had a relatively good clinical prognosis, and neither histological type nor depth of the primary melanoma was clearly related to clinical behavior provided they were completely excised.
In addition to these studies, other retrospective trials from Australia were also presented. 12, 13 In a study of 29 eyelid skin melanoma patients (mean age was 65 years and 15 patients were female) were analyzed at the two regional tertiary referral centers; the most common site of lesions was the lower eyelid (in 18 patients), the lesions were more frequently left-sided (in 19 patients), lentigo maligna melanoma was the most commonly encountered histopathological type (in 19 patients), and 14 patients had in situ disease. 12 Five patients developed local relapses, and four patients developed distant metastases during follow-up after wide excision in all cases. Two patients died, however, the surviving patients had a good outcome. In the largest yet reported study, 56 cases of invasive eyelid skin melanomas from the database of the Melanoma Institute of Australia were investigated. 13 There were predominantly men (n = 31), with median age 66.5 years. The majority of the lesions were located in the lower eyelid (79%), the median Breslow thickness was 1.15 mm, and the most common melanoma subtype was superficial spreading melanoma (57%). Local relapse, nodal involvement, and distant metastasis occurred in 12 (21%), six (11%), and two (4%) patients, respectively, and lower eyelid melanomas were found to have a significantly higher local recurrence rate than upper eyelid melanomas (P = 0.044).
In conclusion, we have found that palpebral melanoma is correlated with some of the favorable prognostic clinico-histopathological variables, predicts a low likelihood for regional lymph nodes involvement, and seldom spreads to the distant organs. The recurrence rate of eyelid melanoma is low and these patients have a better survival outcome. However, the small number of patients and the retrospective design are limitations of our study and might have influenced the final results. That is why we did not perform a multivariate analysis to further explain independent prognostic factors of survival. Despite that, we believe our study will contribute a great deal to the literature. Further studies with larger patient populations are necessary to determine the potential clinical significance of palpebral melanoma. 
